The interest about the link between HF and diabetes is recently growing in the cardiologic scenario after the publication of SGLT2 inhibitors trials, which demonstrated beneficial effects of these drugs in HF patients, which was in fact independent from diabetes itself [49, 50]. The gene discussed is SLC5A2; the disease is hydrops fetalis.